RU2019122801A - Композиция для применения при лечении нарушения мочеполовой системы - Google Patents
Композиция для применения при лечении нарушения мочеполовой системы Download PDFInfo
- Publication number
- RU2019122801A RU2019122801A RU2019122801A RU2019122801A RU2019122801A RU 2019122801 A RU2019122801 A RU 2019122801A RU 2019122801 A RU2019122801 A RU 2019122801A RU 2019122801 A RU2019122801 A RU 2019122801A RU 2019122801 A RU2019122801 A RU 2019122801A
- Authority
- RU
- Russia
- Prior art keywords
- extract
- vaccinium
- amount
- plant
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102016000130012 | 2016-12-22 | ||
IT102016000130012A IT201600130012A1 (it) | 2016-12-22 | 2016-12-22 | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale |
PCT/IB2017/058284 WO2018116238A1 (en) | 2016-12-22 | 2017-12-21 | Composition for use in the treatment of disorders of the urogenital apparatus |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2019122801A true RU2019122801A (ru) | 2021-01-22 |
RU2019122801A3 RU2019122801A3 (it) | 2021-03-26 |
Family
ID=58670171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2019122801A RU2019122801A (ru) | 2016-12-22 | 2017-12-21 | Композиция для применения при лечении нарушения мочеполовой системы |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3558459A1 (it) |
CN (1) | CN110300616A (it) |
IT (1) | IT201600130012A1 (it) |
RU (1) | RU2019122801A (it) |
WO (1) | WO2018116238A1 (it) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3097436B1 (fr) * | 2019-06-24 | 2023-10-13 | Oreal | Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose |
IT201900021483A1 (it) * | 2019-11-18 | 2021-05-18 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Composizioni comprendenti xiloglucano e D-mannosio e loro uso per il trattamento di disturbi del tratto genito-urinario |
EP4076473A1 (en) * | 2019-12-19 | 2022-10-26 | Metagenics, Inc. | Compositions and methods for managing infections of a urinary tract |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0230042D0 (en) * | 2002-12-23 | 2003-01-29 | Britannia Pharmaceuticals Ltd | Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
JP5048238B2 (ja) * | 2005-11-16 | 2012-10-17 | エスエス製薬株式会社 | ウワウルシ乾燥エキス含有経口製剤 |
WO2007144778A2 (en) * | 2006-02-22 | 2007-12-21 | Biologic Health Solutions Pty Ltd. | Herbal compositions for the prevention or treatment of a urinary tract infection |
US20090180999A1 (en) * | 2008-01-11 | 2009-07-16 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition |
ITMI20110409A1 (it) * | 2011-03-15 | 2012-09-16 | Velleja Res Srl | Impiego delle proantocianidine di tipo a2 in forma gastroprotetta per il trattamento della cistiti in fase acuta sostenute da forme batteriche fimbriate |
EP3182982B1 (en) * | 2014-08-19 | 2021-04-28 | Kolinpharma S.p.A. | A composition for the treatment and prevention of urinary tract infections |
-
2016
- 2016-12-22 IT IT102016000130012A patent/IT201600130012A1/it unknown
-
2017
- 2017-12-21 WO PCT/IB2017/058284 patent/WO2018116238A1/en unknown
- 2017-12-21 EP EP17832350.7A patent/EP3558459A1/en active Pending
- 2017-12-21 CN CN201780086737.1A patent/CN110300616A/zh active Pending
- 2017-12-21 RU RU2019122801A patent/RU2019122801A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IT201600130012A1 (it) | 2018-06-22 |
RU2019122801A3 (it) | 2021-03-26 |
WO2018116238A1 (en) | 2018-06-28 |
CN110300616A (zh) | 2019-10-01 |
EP3558459A1 (en) | 2019-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chauhan et al. | Thymol disrupts the membrane integrity of Salmonella ser. typhimurium in vitro and recovers infected macrophages from oxidative stress in an ex vivo model | |
Jaisinghani | Antibacterial properties of quercetin | |
RU2019122801A (ru) | Композиция для применения при лечении нарушения мочеполовой системы | |
Salaheen et al. | Cheap extraction of antibacterial compounds of berry pomace and their mode of action against the pathogen Campylobacter jejuni | |
Castillo et al. | Extracts of edible and medicinal plants in inhibition of growth, adherence, and cytotoxin production of Campylobacter jejuni and Campylobacter coli | |
Islam et al. | Antimicrobial activity of ginger (Zingiber officinale) extracts against food-borne pathogenic bacteria | |
Aliabadi et al. | Antimicrobial activity of olive leaf aqueous extract | |
Yang et al. | Effects of blackberry juice on growth inhibition of foodborne pathogens and growth promotion of Lactobacillus | |
Filocamo et al. | In vitro antimicrobial activity and effect on biofilm production of a white grape juice (Vitis vinifera) extract | |
WO2017049233A3 (en) | Lysin polypeptides active against gram-negative bacteria | |
Abdolshahi et al. | Antibacterial activity of some Lamiaceae species against Staphylococcus aureus in yoghurt-based drink (Doogh) | |
AR076677A1 (es) | Bifidobacterium longum ncc2705 (cncm i-2618) y trastornos inmunes. | |
JP2013522315A5 (it) | ||
PH12019500815A1 (en) | Extract of an herbal composition as antimicrobial and/or antibiofilm agent | |
Supraja et al. | Antibacterial and anticancer activity of silver nanoparticles synthesized from Cynodon dactylon leaf extract | |
EA202190546A1 (ru) | Способы лечения инфекций с применением бактерий | |
Tabari et al. | Comparison of antibacterial effects of Eucalyptus essence, mint essence and combination of them on Staphylococcus aureus and Escherichia coli isolates | |
Mehrnia et al. | Antimicrobial effect of garlic essential oil on a number of food-borne pathogens and determination of its chemical composition and antioxidant potential | |
Rahmeh et al. | Characterization and application of antimicrobials produced by Enterococcus faecium S6 isolated from raw camel milk | |
Cotar | Quorum sensing inhibitors as anti-pathogenic drugs in the fight against Pseudomonas aeruginosa infections | |
Bisignano et al. | 3, 4-DHPEA-EA from Olea Europaea L. is effective against standard and clinical isolates of Staphylococcus sp | |
Li Lei et al. | Study on the antibacterial effects of two Dendrobium polysaccharides. | |
Nahor et al. | Antimicrobial activity of Phyllanthus emblica and Allium sativum: Comparative analysis of antimicrobial action of crude and ethanolic extract of these natural plant products | |
Yousuf et al. | In vitro antibacterial screening of different extracts of Morina longifolia on pathogenic microorganisms | |
Prasad et al. | Antibacterial synergy between oxytetracycline and selected polyphenols against bacterial fish pathogens. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20210924 |